Den Europæiske Union - islandsk - EMA (European Medicines Agency)

gilead sciences ireland uc - sacituzumab govitecan - breast neoplasms; triple negative breast neoplasms - Æxlishemjandi lyf - trodelvy as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic triple-negative breast cancer (mtnbc) who have received two or more prior systemic therapies, including at least one of them for advanced disease.

Den Europæiske Union - islandsk - EMA (European Medicines Agency)

deciphera pharmaceuticals (netherlands) b.v. - ripretinib - gastrointestinal stromal tumors - Æxlishemjandi lyf - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

bayer ab* - dienogestum inn - tafla - 2 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

exeltis healthcare s.l. - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 3 mg/ 0,03 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

atnahs pharma netherlands b.v. - olsalazinum natríum - tafla - 500 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

atnahs pharma netherlands b.v. - olsalazinum natríum - hart hylki - 250 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

bayer ab* - levonorgestrelum inn; ethinylestradiolum inn - tafla

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

norgine b.v. - macrogol 3350; natrii ascorbas inn; sodium sulfate anhydrous; acidum ascorbicum inn; natrii chloridum; kalii chloridum - mixtúruduft, lausn